Legislative committee heard testimony on H.577, a bill to authorize Vermont to join a multistate drug discount card program supported by ArrayRx. Witnesses described likely large price reductions for some prescriptions, raised uncertainty about whether discount‑card payments would count toward plan deductibles/out‑of‑pocket maximums, and recommended clarifying statutory language.